| Rank |
Title |
Journal |
Year |
PubWeight™‹?› |
|
1
|
Translation of research evidence from animals to humans.
|
JAMA
|
2006
|
4.48
|
|
2
|
Statins and sepsis: multiple modifications at multiple levels.
|
Lancet Infect Dis
|
2007
|
2.84
|
|
3
|
Statins: panacea for sepsis?
|
Lancet Infect Dis
|
2006
|
2.32
|
|
4
|
Translating animal research into clinical benefit.
|
BMJ
|
2007
|
2.25
|
|
5
|
Carotid plaque area: a tool for targeting and evaluating vascular preventive therapy.
|
Stroke
|
2002
|
2.10
|
|
6
|
Shift work and vascular events: systematic review and meta-analysis.
|
BMJ
|
2012
|
2.10
|
|
7
|
New fibrate use and acute renal outcomes in elderly adults: a population-based study.
|
Ann Intern Med
|
2012
|
1.91
|
|
8
|
The 2012 Canadian hypertension education program recommendations for the management of hypertension: blood pressure measurement, diagnosis, assessment of risk, and therapy.
|
Can J Cardiol
|
2012
|
1.86
|
|
9
|
Validity of administrative database coding for kidney disease: a systematic review.
|
Am J Kidney Dis
|
2011
|
1.73
|
|
10
|
Impaired renal function modifies the risk of severe hypoglycaemia among users of insulin but not glyburide: a population-based nested case-control study.
|
Nephrol Dial Transplant
|
2010
|
1.65
|
|
11
|
Treating arteries instead of risk factors: a paradigm change in management of atherosclerosis.
|
Stroke
|
2010
|
1.63
|
|
12
|
Contemporary management of dyslipidemia in high-risk patients: targets still not met.
|
Am J Med
|
2006
|
1.54
|
|
13
|
Use of angiotensin-converting enzyme inhibitors or angiotensin receptor blockers and cardiovascular outcomes in chronic dialysis patients: a population-based cohort study.
|
Arch Intern Med
|
2012
|
1.40
|
|
14
|
The 2011 Canadian Hypertension Education Program recommendations for the management of hypertension: blood pressure measurement, diagnosis, assessment of risk, and therapy.
|
Can J Cardiol
|
2011
|
1.38
|
|
15
|
Effects of intensive medical therapy on microemboli and cardiovascular risk in asymptomatic carotid stenosis.
|
Arch Neurol
|
2009
|
1.30
|
|
16
|
The 2010 Canadian Hypertension Education Program recommendations for the management of hypertension: part I - blood pressure measurement, diagnosis and assessment of risk.
|
Can J Cardiol
|
2010
|
1.07
|
|
17
|
Beta-blockers, trimethoprim-sulfamethoxazole, and the risk of hyperkalemia requiring hospitalization in the elderly: a nested case-control study.
|
Clin J Am Soc Nephrol
|
2010
|
1.04
|
|
18
|
Progression of carotid plaque volume predicts cardiovascular events.
|
Stroke
|
2013
|
0.98
|
|
19
|
Retracted
Low sodium versus normal sodium diets in systolic heart failure: systematic review and meta-analysis.
|
Heart
|
2013
|
0.96
|
|
20
|
Risk of acute kidney injury from oral acyclovir: a population-based study.
|
Am J Kidney Dis
|
2013
|
0.96
|
|
21
|
Hospital admissions for hyperkalemia with trimethoprim-sulfamethoxazole: a cohort study using health care database codes for 393,039 older women with urinary tract infections.
|
Am J Kidney Dis
|
2011
|
0.92
|
|
22
|
Carvedilol: a third-generation β-blocker should be a first-choice β-blocker.
|
Expert Rev Cardiovasc Ther
|
2012
|
0.86
|
|
23
|
Lipoprotein(a) is associated differentially with carotid stenosis, occlusion, and total plaque area.
|
Arterioscler Thromb Vasc Biol
|
2008
|
0.86
|
|
24
|
Discordance between physicians' estimation of patient cardiovascular risk and use of evidence-based medical therapy.
|
Am J Cardiol
|
2008
|
0.83
|
|
25
|
Beta-blockers and cardiovascular outcomes in dialysis patients: a cohort study in Ontario, Canada.
|
Nephrol Dial Transplant
|
2011
|
0.82
|
|
26
|
The relationship of carotid three-dimensional ultrasound vessel wall volume with age and sex: comparison to carotid intima-media thickness.
|
Ultrasound Med Biol
|
2012
|
0.81
|
|
27
|
Effects of aldosterone on human atherosclerosis: plasma aldosterone and progression of carotid plaque.
|
Can J Cardiol
|
2012
|
0.81
|
|
28
|
Translation of genetic discoveries into clinical therapies.
|
Ann Intern Med
|
2008
|
0.78
|
|
29
|
Lifetime risk prediction in cardiovascular prevention: wave of the future?
|
Can J Cardiol
|
2012
|
0.78
|
|
30
|
Keloid scarring, but not Dupuytren's contracture, is associated with unexplained carotid atherosclerosis.
|
Clin Invest Med
|
2009
|
0.77
|
|
31
|
Pulmonary abnormalities and carotid atherosclerosis in ex-smokers without airflow limitation.
|
COPD
|
2014
|
0.77
|
|
32
|
Predicting stroke risk in patients with atrial fibrillation.
|
Stroke
|
2007
|
0.75
|
|
33
|
Drug treatment of hypertension. Conclusion of editorial is somewhat flawed.
|
BMJ
|
2003
|
0.75
|
|
34
|
Medical management of peripheral arterial disease.
|
JAMA
|
2006
|
0.75
|
|
35
|
Selective serotonin reuptake inhibitors and surgery: to hold or not to hold, that is the question: comment on "Perioperative use of selective serotonin reuptake inhibitors and risks for adverse outcomes of surgery".
|
JAMA Intern Med
|
2013
|
0.75
|
|
36
|
The PROGRESS trial three years later: Clear and accurate interpretations of studies are needed.
|
BMJ
|
2004
|
0.75
|
|
37
|
Managing hypertension: evidence supporting the 2013/2014 recommendations of the Canadian Hypertension Education Program.
|
CMAJ
|
2014
|
0.75
|
|
38
|
Management of risk factors among ambulatory patients at high cardiovascular risk in Canada: a follow-up study.
|
Can J Cardiol
|
2013
|
0.75
|
|
39
|
Underrepresentation of peripheral artery disease in modern cardiovascular trials: systematic review and meta-analysis.
|
Int J Cardiol
|
2013
|
0.75
|
|
40
|
Lost Productivity in Stroke Survivors: An Econometrics Analysis.
|
Neuroepidemiology
|
2016
|
0.75
|